Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KRT35 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DOCK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GJA3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
CD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2W - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF704 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STK31 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FGF12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OR5P2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLRD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DAPP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GOLGA6L6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
IQGAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FMN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DAPL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on